Brown Advisory’s Adverum Biotechnologies ADVM Stock Holding History

Brown Advisory’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,058	Closed	-$64K	–	1250
2018 Q3	$64K	Sell	1,058 -508	-32%	-$28.5K	﹤0.01%	1307
2018 Q2	$83K	Sell	1,566 -33	-2%	-$1.98K	﹤0.01%	1256
2018 Q1	$93K	Buy	+1,599	New	+$99.6K	﹤0.01%	1143

Other funds holding ADVM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Brown Advisory's ADVM Position: Q4 2018 in Review

Brown Advisory sold out of Adverum Biotechnologies (ADVM) in Q4 2018, closing a stake of 1,058 shares — an estimated $64K sold.

Brown Advisory first reported a position in ADVM in Q1 2018 and held it in 3 quarters. The position peaked at $93K in Q1 2018. 86 funds tracked by Wall St. Rank hold ADVM as of Q4 2018.

Brown Advisory reported no remaining Adverum Biotechnologies position as of Q4 2018 after selling out during the quarter.
Brown Advisory sold 1,058 Adverum Biotechnologies shares in Q4 2018, an estimated $64K.
Brown Advisory first reported a position in Adverum Biotechnologies in Q1 2018 and held it in 3 quarters.
Brown Advisory's Adverum Biotechnologies position peaked at $93K in Q1 2018.
86 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2018.

Based on Brown Advisory's 13F filing for Q4 2018, filed 13 Feb 2019.